PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, United States of America.\', \'Facultad de Medicina, Campus Tijuana, Universidad Xochicalco, Baja California, Mexico.\', \'United States-Mexico Border Health Commission, Tijuana, Baja California, Mexico.\', \'Departmento de Estudios de PoblaciĆ³n, El Colegio de la Frontera Norte, Tijuana, Baja California, Mexico.\', \'Department of Medicine, San Diego Center for AIDS Research Translational Virology Core, University of California San Diego, La Jolla, CA, United States of America.\', \'School of Public Health, San Diego State University, San Diego, California, United States of America.\', \'Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0260286
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34807963
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all